Monalisa Co (012690) Fair Value & Analysis
Consumer Defensive · KR · Market cap 61.8B KRW
Fair value as of: Jul 22, 2026
From 13 valuation models · updated 19 days ago
Share price +7.3% over the past month.
A solid business, but screening 54% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (870.33 KRW). The favourable scenario is already priced in.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range 1,344 KRW – 5,129 KRW · fair‑value band 522.20 KRW – 870.33 KRW · the 1,510 KRW price screens above the 696.27 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.
Analysis
Monalisa Co (012690) currently trades at 1,510 KRW, while our model-based Fair Value estimate is 696.27 KRW, implying the stock looks roughly 53.9% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Monalisa Co generated revenue of 109B KRW at a net margin of -0.8%. Revenue declined 6.9% year over year. It earns a return on equity of -1.3%. Fundamentals as of Jul 22, 2026
Our scenario range runs from 522.20 KRW (bear case) to 870.33 KRW (bull case); at 1,510 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 45% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -54%, 012690 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Asset-Based (1,602 KRW) versus Earnings-Based (254.94 KRW). Highest evidence: Residual Income (76).
Notify me when 012690 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 55 · Market factors (momentum, volatility) 13
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Monalisa Co., Ltd engages in the production and sale of hygiene products in South Korea. It offers sanitary tissue, bathroom tissue, facial tissue, wet tissue, and kitchen towel products, as well as wet wipes, adult diapers, baby diapers, masks, napkins, jumbo rolls, and paper towels under the Bellagio, The Rich House, and Nox Premium brand names.
Full company description
Monalisa Co., Ltd engages in the production and sale of hygiene products in South Korea. It offers sanitary tissue, bathroom tissue, facial tissue, wet tissue, and kitchen towel products, as well as wet wipes, adult diapers, baby diapers, masks, napkins, jumbo rolls, and paper towels under the Bellagio, The Rich House, and Nox Premium brand names. The company was founded in 1977 and is headquartered in Seoul, South Korea. As of November 7, 2024, Monalisa Co., Ltd operates as a subsidiary of Arch Peninsula SDN.BHD..
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Monalisa Co reported revenue of 124B KRW in FY2025 versus 106B KRW in FY2021, a compound +3.9%/yr. Reported net income was 1.5B KRW in FY2025, compounding −17.7%/yr from FY2021.
012690 screens 54% overvalued. Compare with The Procter & Gamble Company →
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 1,273 MXN | +18% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,144 | ₹1,000 | -53% |
| Essity AB ESSITYA | kr 279.00 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹1,088 | ₹367.64 | -66% |
| Marico Limited MARICO | ₹846.75 | ₹233.05 | -72% |
| APR Co 278470 | 375,000 KRW | 151,222 KRW | -60% |
| Dabur India Limited DABUR | ₹429.45 | ₹181.60 | -58% |
| Kimberly-Clark de México, S. A. B. de C. V., KIMBERA | 38.07 MXN | 50.09 MXN | +32% |
| PT Unilever Indonesia Tbk UNVR | 1,730 IDR | 1,934 IDR | +12% |
Compare Monalisa Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Monalisa Co (012690) overvalued or undervalued?
What is the fair value of 012690?
What is the quality score of 012690?
What is the revenue of Monalisa Co (012690)?
What is the net profit margin of 012690?
Does Monalisa Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Monalisa Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.